Human Milk Oligosaccharides (HMO) Market Report Scope & Overview:

Human Milk Oligosaccharides (HMO) Market size was valued at $187.07 million in 2022, and is estimated to reach $912.13 million by 2030, registering a CAGR of 21.9% from 2023 to 2030.

Human milk oligosaccharide (HMO) is a class of primarily intricate, unconjugated glycans found in high focuses in human milk. HMOs are negligibly processed in the gastrointestinal framework and arrive at the colon flawless, where they shape the miniature biota.

As HMOs are valuable for invulnerability, a few new strategies are being created by central members in the Human Milk Oligosaccharides (HMO) market, for example, detaching HMO from cow milk, utilizing expensive procedures (artificially or enzymatic-ally orchestrating), or using organisms to deliver them. Human Milk Oligosaccharides (HMO) market things are exorbitant, as a ton of human milk is consolidated to convey an unobtrusive amount of HMO. Thus, methods for combination and extraction are improving with consistent innovative work exercises.

Human Milk Oligosaccharides (HMO) Market Revenue Analysis

The worldwide HMO market has been affected by a portion of the macroeconomic and microeconomic elements saw in a few key nations. This would demonstrate sufficiently able to drive the market fundamentally concerning esteem deals during the gauge time frame. With the ascent in number of babies across the globe, the interest and inclination for HMO-based baby recipe alongside the pattern of embracing sound way of life by devouring practical food and refreshments has fundamentally helped the use of HMO in assembling.

The Human Milk Oligosaccharides (HMO) market is supposed to observe huge income age during the estimated time frame, attributable to increment in application scope in utilitarian food and drinks and baby equation, fast mechanical headway in the product offering, ascend in well-being mindfulness, and quick improvement of the dairy business.

Market Dynamics:

Driving Factors:

  • Development in well-being mindfulness prompts expanded utilization of dietary enhancements.

  • HMOs are interesting, stomach reinforcing supplements, experimentally demonstrated to help stomach related well-being and resistance.

Restraining Factors:

  • Digitization of retail industry


  • The presentation of advancements like epitome, nanoencapsulation, and bio-embodiment


  • The shortfall of marking for reciprocal well-being administrations in addition to conflicting publicizing messages and visual lines.

Impact Of Covid-19:

The COVID-19 pandemic fundamentally affected the Human Milk Oligosaccharides (HMO) market. The interest for HMO expanded during the lockdown because of frenzy purchasing for at-home utilization during the underlying period of the pandemic. Subsequently, the deals of HMOs heightened during the pandemic, because of the way that it fills in as an insusceptibility promoter.

Key Market Segmentation:

By Type:

  • 2’ Fl

  • 3’ Fl

  • 3’ Sl

  • 6’ Sl

By Application:

  • Infant Formula

  • Functional Food & Beverages

  • Food Supplement

By Concentration:

  • Acidic

  • Neutral

By Distribution Channel:

  • Hypermarkets and supermarkets

  • Drug stores or pharmacy

  • Mass merchandiser

  • Departmental stores

  • Mono-brand stores

  • Specialty stores

  • Online sales channel

Human Milk Oligosaccharides (HMO) Market Segmentation Analysis

Expanding well-being mindfulness alongside the rising utilization of baby recipe is probably going to help the development of the HMO market over the conjecture time frame. The utilization of HMOs has contributed altogether to achieving a significant decrease in the worldwide baby death rate throughout the long term. According to the United Nations International Children's Education Fund (UNICEF), the under-five death rate was one for every 11 youngsters in 1990 which dropped to one for every 26 kids in 2018.

Contingent upon dispersion channel, the pharmacy or drug store section drove the Human Milk Oligosaccharides (HMO) market in 2020. This is credited to the way that to draw in and hold clients during the developing contest from mail-request retailers and supercenters, pharmacy administrators have underlined comfort factors like broadened store hours and drive-through areas.


  • North America

    • USA

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • The Netherlands

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • south Korea

    • China

    • India

    • Australia

    • Rest of Asia-Pacific

  • The Middle East & Africa

    • Israel

    • UAE

    • South Africa

    • Rest of Middle East & Africa

  • Latin America

    • Brazil

    • Argentina

    • Rest of Latin America

Key Players:

Abbott Laboratories, BASF S.E., Biosynth Carbosynth, Chr. Hansen Holding A/S, Dextra Laboratories Ltd., Dupont Nutrition & Biosciences, Elicityl S.A., Glycom A/S, Glycosyn, Inbiose NV, Medolac Laboratories, Neolacta Lifesciences Pvt. Ltd, Nestle Health Science, Royal DSM, and ZuChem.

Biosynth Carbosynth-Company Financial Analysis

Company Landscape Analysis

Human Milk Oligosaccharides (HMO) Market Report Scope:
Report Attributes Details
Market Size in 2022 US$ 187.07 Million
Market Size by 2030 US$ 912.13 Million
CAGR CAGR 21.9% From 2023 to 2030
Base Year 2022
Forecast Period 2023-2030
Historical Data 2020-2021
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • by Type (2’ Fl, 3’ Fl, 3’ Sl, 6’ Sl)
• by Application (Infant Formula, Functional Food & Beverages, Food Supplement)
• by Concentration (Acidic, Neutral)
Regional Analysis/Coverage North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
Company Profiles Abbott Laboratories, BASF S.E., Biosynth Carbosynth, Chr. Hansen Holding A/S, Dextra Laboratories Ltd., Dupont Nutrition & Biosciences, Elicityl S.A., Glycom A/S, Glycosyn, Inbiose NV, Medolac Laboratories, Neolacta Lifesciences Pvt. Ltd, Nestle Health Science, Royal DSM, and ZuChem.
Key Drivers •Development in well-being mindfulness prompts expanded utilization of dietary enhancements.
Restraints •Digitization of retail industry

Frequently Asked Questions

Ans: HMO market is segmented in types, applications, distribution channels, and concentration.

Ans: Competitive companies in the HMO Market are Abbott Laboratories, BASF S.E., Biosynthesis Carbosynth, Chr. Hansen Holding A/S, Dextra Laboratories Ltd., Dupont Nutrition & Biosciences, Elicityl S.A., Glycom A/S, Glycosyn, Inbiose NV, Medolac Laboratories, Neolacta Lifesciences Pvt. Ltd, Nestle Health Science, Royal DSM, and ZuChem.

Ans: 2'FL market holds the most extreme piece of the pie of the HMO market.

Ans: The base year determined in the HMO market report is 2021.

Ans: The global human milk oligosaccharides (HMO) market size is estimated to reach $613.84 million by 2028, registering a CAGR of 21.9% from 2021 to 2028. 

Table of Contents


1. Introduction

1.1 Market Definition

1.2 Scope

1.3 Research Assumptions

2. Research Methodology

3. Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

4. Impact Analysis

4.1 COVID-19 Impact Analysis

4.2 Impact of Ukraine- Russia war

4.3 Impact of ongoing Recession

4.3.1 Introduction

4.3.2 Impact on major economies US Canada Germany France United Kingdom China Japan South Korea Rest of the World

5. Value Chain Analysis

6. Porter’s 5 forces model

7.  PEST Analysis

8. HMO Market Segmentation on the basis of Type

8.1 2’ Fl

8.2 3’ Fl

8.3 3’ Sl

8.4 6’ Sl

9. HMO Market Segmentation on the basis of Application

9.1 Infant Formula

9.2 Functional Food & Beverages

9.3 Food Supplement

10. HMO Market Segmentation on the basis of Concentration

10.1 Acidic

10.2 Neutral

11. HMO Market Segmentation on the basis of distribution channel,

11.2 Hypermarkets and supermarkets

11.3 Drug stores or pharmacy

11.4 Mass merchandiser

11.5 Departmental stores

11.6 Mono-brand stores

11.7 Specialty stores

11.8 Online sales channel

12. Regional Analysis

12.1 Introduction

12.2 North America

12.2.1 USA

12.2.2  Canada

12.2.3  Mexico

12.3 Europe

12.3.1  Germany

12.3.2  UK

12.3.3  France

12.3.4  Italy

12.3.5  Spain

12.3.6  The Netherlands

12.3.7  Rest of Europe

12.4 Asia-Pacific

12.4.1  Japan

12.4.2  South Korea

12.4.3  China

12.4.4  India

12.4.5  Australia

12.4.6  Rest of Asia-Pacific

12.5 The Middle East & Africa

12.5.1  Israel

12.5.2  UAE

12.5.3  South Africa

12.5.4  Rest

12.6 Latin America

12.6.1  Brazil

12.6.2  Argentina

12.6.3  Rest of Latin America

13. Company Profiles

13.1 Abbott Laboratories

13.1.1 Financial

13.1.2 Products/ Services Offered

13.1.3 SWOT Analysis

13.1.4 The SNS view

13.2 BASF S.E.

13.3 Biosynth Carbosynth

13.4 Chr. Hansen Holding A/S

13.5 Dextra Laboratories Ltd.

13.6 Dupont Nutrition & Biosciences

13.7 Elicityl S.A.

13.8 Glycom A/S

13.9 Glycosyn

13.10 Inbiose N

13.11 Medolac Laboratories

13.12 Neolacta Lifesciences Pvt. Ltd

13.13 Nestle Health Science

13.13 Royal DSM

13.15 ZuChem

15. Competitive Landscape

15.1 Competitive Benchmarking

15.2 Market Share analysis

15.3 Recent Developments

16. Conclusion

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.


The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Primary Research

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Data Bank Validation

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.

Start a Conversation

Hi! Click one of our member below to chat on Phone